by GlobeNewsWire | Sep 14, 2017 | Globe Newswire
VANCOUVER, British Columbia, Sept. 14, 2017 (GLOBE NEWSWIRE) — CounterPath Corporation (“CounterPath”) (NASDAQ:CPAH) (TSX:PATH), a global provider of award-winning, over-the-top (OTT) Unified Communications (UC) solutions for enterprises and carriers, announced...
by GlobeNewsWire | Sep 14, 2017 | Globe Newswire
BRIDGEVILLE, Pa., Sept. 14, 2017 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq:USAP) announced today that it experienced a fire at its Dunkirk, New York facility. The fire originated and was contained within the steel pickling area of...
by GlobeNewsWire | Sep 14, 2017 | Globe Newswire
VANCOUVER, British Columbia, Sept. 14, 2017 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSX.V:EXG) (OTC:BXXRF) (“ExGen”) announces that the Board of Directors of ExGen, upon the recommendation of the Corporate Governance and Compensation Committee of ExGen, have...
by GlobeNewsWire | Sep 14, 2017 | Globe Newswire
RADNOR, Pa., Sept. 14, 2017 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or the “Company”) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to...
by GlobeNewsWire | Sep 14, 2017 | Globe Newswire
CRANBURY, N.J., Sept. 14, 2017 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) announced that Health Canada has approved the oral precision medicine Galafold for long-term treatment of adults with a confirmed diagnosis of Fabry disease [deficiency of...
